how many americans on glp 1 Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Gallup | More Americans are
Description
The GLP-1 market is projected
By 2030, the global prevalence of obesity is expected to reach one billion
These products are not assessed for safety, quality, or effectiveness, and could pose serious risks to consumers
GLP-1 medications like Ozempic and Mounjaro can cause fatigue, muscle loss, and balance issues
Just 1 scoop(6g) a daymix easily into water, shakes, or your favorite beverage,30 minutes before meals
Worried about appetite suppressant side effects
